3. NMA results for OS (IMDC favourable risk group).
Results of network meta‐analysis for outcome overall survival (IMDC favourable risk group). Treatments are ordered by P‐Score (descending). Only subnetworks with >1 designs. Upper triangle: direct estimate. Lower triangle: network estimate. Subnet 1 No. of studies: 5. No. of pairwise comparisons: 5. No. of treatments: 6. No. of designs: 5 Heterogeneity/Inconsistency: Q = 0, df = 0, P = n.a.; I²=n.a., Tau² = n.a. Treatment Effects + 95%‐CIs (Hazard ratios, random‐effects model): | |||||
AVE+AXI | . | . | . | 0.66 [0.36, 1.22] | . |
0.71 [0.34, 1.48] | NIV+IPI | . | . | 0.93 [0.62, 1.40] | . |
0.70 [0.27, 1.80] | 0.99 [0.43, 2.25] | NIV+CAB | . | 0.94 [0.46, 1.92] | . |
0.65 [0.24, 1.77] | 0.92 [0.38, 2.22] | 0.93 [0.32, 2.68] | LEN+EVE | 1.01 [0.46, 2.20] | . |
0.66 [0.36, 1.22] | 0.93 [0.62, 1.40] | 0.94 [0.46, 1.92] | 1.01 [0.46, 2.20] | SUN | 0.87 [0.42, 1.82] |
0.57 [0.22, 1.50] | 0.81 [0.35, 1.88] | 0.82 [0.29, 2.28] | 0.88 [0.30, 2.57] | 0.87 [0.42, 1.82] | LEN+PEM |